Diary

  • Thu
    09
    Dec
    2021
    Fri
    10
    Dec
    2021

    10am - 12.30pmOnline, live event


    Description:
    Over the course the first morning, Elaine guides you through the scientific concepts that underpin many of the most used targeted cancer treatments for solid tumours.

    Elaine begins by describing what we can and can't target, and the mechanisms of action of monoclonal antibodies and small molecules that block kinases. She then looks at the many treatments that block growth factor controlled signalling pathways. Finally, she turns her attention to other targets and to various biomarker tests to select the right approach for each patient.

    On the second morning the focus is on cancer’s relationship with the immune system, and how this knowledge is being used to improve the outlook of people with many different cancer types. Checkpoint inhibitors (e.g. nivolumab, pembrolizumab) will take centre-stage.

    Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine's other courses
    Cost:
    £50 per morning
    To book, contact: conferenceteam@rmh.nhs.uk or book online
    View a PDF of the programme

  • Thu
    03
    Feb
    2022
    Fri
    04
    Feb
    2022

    10am - 12.30pmOnline, live event


    Format:
    This is a live, virtual event. Each morning’s content is split over three pre-recorded videos of 30-40 minutes each. Elaine will be online throughout both mornings to interact with learners and answer questions in the live Q&A sessions that follow each video. The presentations will be available online for 30 days after the live event.

    Description:

    The aim of this course, spread over two mornings, is to provide learners with a good, general understanding of the biology, genetics and behaviours of many haematological cancers. Elaine also provides an up-to-date overview of modern systemic treatment approaches given to people with various haematological cancers. This includes CAR T cell therapy and other targeted approaches that have come through clinical trials in recent years.

    Elaine's goal is to explain the science that underpins each treatment. She also hopes to provide learners with a broad understanding of why treatments work well for some patients but not for others.

    Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine's other courses
    Cost:
    £50 per morning
    To book, contact: conferenceteam@rmh.nhs.uk, or book online

    View the programme

  • Mon
    25
    Apr
    2022
    Tue
    26
    Apr
    2022

    10am - 12.30pmOnline, live event

     

    Format: This is a live, virtual event. Each morning’s content is split over three sessions of 30-40 minutes each. Elaine will be online throughout both mornings to interact with learners and answer questions in the live Q&A sessions that follow each presentation. Recordings of the presentations will be available online for 30 days after the live event.

    Description: Over the course of two mornings, Elaine will guide you through many of the most relevant topics relating to modern systemic treatments for non-small cell lung cancer (NSCLC).
    The first morning’s focus is on the gene faults that drive many NSCLCs and on the targeted treatments that exploit these faults, such as inhibitors of EGFR, ALK, ROS1, B-Raf, HER2, MET and RET.
    The second morning is about cancer’s relationship with the immune system and on the checkpoint inhibitor group of immunotherapies, which include PD-1, PD-L1 and CTLA-4 targeted antibody therapies.
    As ever, Elaine's presentations are full of colourful and enlightening illustrations to help you make sense of scientific concepts. Her descriptions avoid unnecessary jargon and are pitched so that even those with a relatively limited understanding of cell biology are able to understand.

    Audience: This content is ideal for research nurses, clinical nurse specialists, pharmacists and clinical trials coordinators. It may also be of interest to other healthcare professionals involved in the diagnosis and treatment of people with lung cancer.

    Cost: £50 per morning; the content will be available for 30 days after the event

    To book, contact: conferenceteam@rmh.nhs.uk or book online

    View a PDF of the programme

  • Thu
    09
    Jun
    2022

    10am - 12.30pmVirtual, online


    Format: 
    This is a live, virtual event. The content is split over three sessions of 30-40 minutes each. Elaine will be online throughout to interact with learners and answer questions in the live Q&A sessions that follow each presentation. Recordings of the presentations will be available online for 30 days after the live event.

    Description: Elaine describes cancer’s relationship with the immune system and the science behind many different types of immunotherapy. Treatments covered include checkpoint inhibitors (e.g. ipilimumab, pembrolizumab, nivolumab), cell-based treatments (CAR T cell therapy, TCR-engineered T cells), and vaccine-based treatments (peptide, dendritic cell, oncolytic viruses).

    Audience: Ideal for anyone with an A level or equivalent understanding of cell biology and genetics and who works with cancer patients, data or treatments.

    Cost: £50

    To book, contact: conferenceteam@rmh.nhs.uk or book online

    View a PDF of the programme

  • Mon
    04
    Jul
    2022

    10am - 12.30pmOnline, live event

    Format: This is a live, virtual event. Each morning’s content is split over three sessions of 30-40 minutes each. Elaine will be online throughout both mornings to interact with learners and answer questions in the live Q&A sessions that follow each presentation. Recordings of the presentations will be available online for 30 days after the live event.

    Description: This morning Elaine provides an up-to-date overview of the science behind targeted treatments and immunotherapies for people with malignant melanoma. She begins with the gene mutations that cause melanoma and describes the biology of this disease and its relationship with the immune system. She then describes various treatment approaches, such as B-Raf and MEK inhibitors and immunotherapy with checkpoint inhibitors.

    Elaine's goal is to explain the science that underpins each treatment and to provide learners with a broad understanding of why treatments work well for some patients but not for others.

    Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine's other courses

    Cost: £50

    To book, contact: conferenceteam@rmh.nhs.uk
    View a PDF of the programme

  • Tue
    05
    Jul
    2022

    10am - 12.30pmOnline, live event

    Format: This is a live, virtual event. Each morning’s content is split over three sessions of 30-40 minutes each. Elaine will be online throughout both mornings to interact with learners and answer questions in the live Q&A sessions that follow each presentation. Recordings of the presentations will be available online for 30 days after the live event.

    Description: In this course Elaine provides an up-to-date overview of bowel cancer biology and genetics and the science behind various treatment approaches. Including monoclonal antibodies targeting EGFR, and small molecule such as B-Raf inhibitors. She also describes the rationale behind checkpoint inhibitors for selected patients, and discusses treatment approaches in trials.

    Elaine's goal is to explain the science that underpins each treatment and to provide learners with a broad understanding of why treatments work well for some patients but not for others.

    Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine's other courses

    Cost: £50

    To book, contact: conferenceteam@rmh.nhs.uk

    View a PDF of the programme

  • Mon
    05
    Sep
    2022
    Tue
    06
    Sep
    2022

    10am - 12.30pmOnline, live event


    Format:
    This is a live, virtual event. Each morning’s content is split over three presentations of ~40 minutes each. Elaine will be online throughout both mornings to interact with learners and answer questions in the live Q&A sessions that follow each presentation. Videos of the presentations will be available online for 30 days after the live event.

    Description: This course is designed specifically for those new to cancer, or those wishing to refresh their knowledge. In the first morning Elaine will provide an overview of the mechanisms of action of chemotherapy, hormone therapy, targeted therapy and immunotherapy. In the second, she will describe what biomarkers are, where they’re found, how they’re detected, and what they’re used for. Topics include genetic analysis, so-called “virtual biopsies”, and how biomarkers can give both prognostic and predictive information.

    Audience: This course is ideal for nurses who are new to caring for cancer patients or who wish to refresh and expand their knowledge. This course is also suitable for anyone involved in cancer research and trials.

    Cost: £50 per morning
    To book, contact: conferenceteam@rmh.nhs.uk

    View a PDF of the programme